Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 53

    Global medical-tech firms, India locked in tussle after stent price sting

    Global medical-tech firms, India locked in tussle after stent price sting

    supriya kashyap kashyap30 April 2017 12:12 PM IST
    New Delhi/Mumbai : A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures...
    Government Prohibits Stent companies to withdraw stents for Next Six Months

    Government Prohibits Stent companies to withdraw stents for Next Six Months

    Ruby Khatun Khatun25 April 2017 3:12 PM IST
    New Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government...
    Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

    Drug controllers seize spurious and expired medicines worth Rs 10 crore in Patna

    Ruby Khatun Khatun23 April 2017 1:38 PM IST
    Patna: Bihar Drug Controller and Bihar police recently raided the godowns of a drug company and seized fake and expired medicines worth over Rs 10...
    Unfortunate: Biotech firm pulls pioneering gene therapy due to no demand

    Unfortunate: Biotech firm pulls pioneering gene therapy due to no demand

    Ruby Khatun Khatun23 April 2017 10:17 AM IST
    By Ben HirschlerLONDON: The biotech company behind the Western world's first gene therapy and the most expensive prescription medicine in history is...
    NPPA to penalise companies offering freebies on stent sales

    NPPA to penalise companies offering freebies on stent sales

    supriya kashyap kashyap21 April 2017 10:55 AM IST
    New Delhi : Drug price regulator NPPA warned coronary stent manufacturing firms of strict action if they are found giving freebies on sale of the...
    PMs push for generic drugs to shift focus to chemists, says pharma industry body

    PM's push for generic drugs to shift focus to chemists, says pharma industry body

    supriya kashyap kashyap19 April 2017 11:41 AM IST
    New Delhi : Patients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines as indicated by...
    ASPA lobbies for mandatory authentication for medicines

    ASPA lobbies for mandatory authentication for medicines

    supriya kashyap kashyap14 April 2017 11:23 AM IST
    Kolkata : The Authentication Solution Providers Association (ASPA) emphasised the need for specific anti-counterfeit laws in the country to stem the...
    Taking steps to discourage import of bulk drugs: Government

    Taking steps to discourage import of bulk drugs: Government

    supriya kashyap kashyap12 April 2017 12:10 PM IST
    New Delhi : Government is taking various policy initiatives, including withdrawal of customs duty exemption, to discourage import of bulk drugs and...
    FDA approves first drug to treat tardive dyskinesia

    FDA approves first drug to treat tardive dyskinesia

    supriya kashyap kashyap12 April 2017 12:09 PM IST
    The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug...
    Attention Cardiologists: Please Report adverse events related to Abbott

    Attention Cardiologists: Please Report adverse events related to Abbott's BVS stents to CDSCO

    savita thakur thakur11 April 2017 1:28 PM IST
    Patients and healthcare professionals are advised to report adverse events suspected to be associated with the use of Absorb Bioresorbable Vascular...
    Anti-dumping duty likely on Amoxycillin import from China

    Anti-dumping duty likely on Amoxycillin import from China

    supriya kashyap kashyap11 April 2017 11:48 AM IST
    New Delhi : India may impose anti-dumping duty of up to USD 8.71 per kg on Amoxycillin, an anti-biotic medicine, from China to ringfence domestic...
    FDA allows marketing of first direct-to-consumer Gene Test

    FDA allows marketing of first direct-to-consumer Gene Test

    supriya kashyap kashyap10 April 2017 11:35 AM IST
    The US Food and Drug Administration allowed marketing of 23 and Me Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok